Founded in 2013, MedPacto, Inc. is a South Korean biopharmaceutical company specializing in the research and development of therapeutics targeting cancer and autoimmune diseases. The company's mission is to contribute to humanity by developing innovative and personalized therapies.

Biomarker-Based Drug Development: MedPacto focuses on developing therapeutics based on specific biomarkers, aiming to create personalized treatment options for patients.

Public

Biotech